TrialLeukemia research2012

Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na.

Mahesh Seetharam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.